
51 - 200 employés
Fondée en 2019
🧬 Biotechnologie
💊 Pharmaceutique
🔬 Science
💰 €85 000 000 Series B en 2022-01
Biotechnology • Pharmaceuticals • Science
Kyverna Therapeutics est une entreprise biopharmaceutique en phase clinique, axée sur le patient, qui développe des thérapies cellulaires pour les patients souffrant de maladies auto-immunes. L'entreprise est pionnière dans les thérapies CAR T-cell, tirant parti du pouvoir transformationnel des cellules T pour potentiellement offrir une rémission durable sans traitement pour les maladies auto-immunes. Le principal candidat de thérapie CAR T-cell de Kyverna, KYV-101, progresse à travers des essais cliniques ciblant diverses maladies auto-immunes, y compris la sclérose en plaques, la myasthénie grave, la sclérodermie systémique et la néphrite lupique. Leur pipeline comprend des thérapies innovantes utilisant des récepteurs antigéniques chimériques (CAR) T-cell, tant dans les formats autologues qu'allogéniques, destinées aux maladies auto-immunes médiées par les cellules B.
🕒 il y a 4 mois
🇺🇸 États-Unis – Télétravail
💵 $330 000 - $370 000 / an
⏰ Temps Plein
🟠 Senior
👨⚕️ Directeur Médical
👻 Score fantôme 48%
🗣️🇺🇸🇬🇧 Anglais requis
Améliorez vos chances d'obtenir un entretien en vérifiant votre score de CV avant de postuler.

51 - 200 employés
Fondée en 2019
🧬 Biotechnologie
💊 Pharmaceutique
🔬 Science
💰 €85 000 000 Series B en 2022-01
Biotechnology • Pharmaceuticals • Science
Kyverna Therapeutics est une entreprise biopharmaceutique en phase clinique, axée sur le patient, qui développe des thérapies cellulaires pour les patients souffrant de maladies auto-immunes. L'entreprise est pionnière dans les thérapies CAR T-cell, tirant parti du pouvoir transformationnel des cellules T pour potentiellement offrir une rémission durable sans traitement pour les maladies auto-immunes. Le principal candidat de thérapie CAR T-cell de Kyverna, KYV-101, progresse à travers des essais cliniques ciblant diverses maladies auto-immunes, y compris la sclérose en plaques, la myasthénie grave, la sclérodermie systémique et la néphrite lupique. Leur pipeline comprend des thérapies innovantes utilisant des récepteurs antigéniques chimériques (CAR) T-cell, tant dans les formats autologues qu'allogéniques, destinées aux maladies auto-immunes médiées par les cellules B.
• Serve as the physician lead for CAR T-cell therapy clinical trials in autoimmune disease indications, in partnership with internal and external cross-functional teams. • Oversee medical monitoring of clinical trials, including engagement with site investigators and external medical monitors. • Partner with clinical operations, biometrics, regulatory, and commercial teams to ensure alignment on strategy and execution. • Lead design, execution, and interpretation of clinical trials across assigned program. • Provide medical and scientific input into clinical development plans, study protocols, investigator brochures, and regulatory submissions. • Review, analyze, and interpret safety, efficacy, PK, and biomarker data. • Develop clinical trial documents including protocols, ICFs, clinical development plans, and publications. • Lead development of clinical sections of regulatory documents including the IB, safety updates, clinical study reports, and responses to Health Authorities. • Engage with external investigators and researchers to identify, evaluate, and support investigator-sponsored studies and drive research collaborations. • Report to the SVP, Clinical Development & Medical Affairs.
• MD, DO, (or ex-US equivalent) or MD-PhD degree required. • 5+ years of clinical research experience with 3+ years of industry experience in late phase clinical development involved in the design and execution of clinical trials. • Specialty training in neurology, rheumatology, nephrology and/or industry experience in clinical development of cell therapies and/or therapies for autoimmune diseases is highly preferred. • Proven ability to interpret, discuss and present efficacy and safety data. • Strong knowledge of GCP/ICH, clinical trial design, clinical development processes, and regulatory requirements. • Strong ability to communicate and establish effective working relationship with investigators, collaborators, scientific advisors, CROs, and corporate partners.
• Bonus eligibility • Participation in Company’s stock plan • Benefits package
Postuler Maintenant🕒 il y a 4 mois
Medical Director overseeing medical aspects of clinical trials at Thermo Fisher Scientific. Ensuring compliance with regulations and delivering high-quality medical oversight in the pharmaceutical product life-cycle.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 4 mois
Market Physician Executive managing in-home multi-specialty care models at Monogram Health. Focused on improving health outcomes, patient experience, and operational performance for complex patients.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 4 mois
Senior Clinical Development Medical Director leading and executing clinical trials for oncology products. Collaborating with clinical teams to drive innovative drug development and interpretation of study results.
🇺🇸 États-Unis – Télétravail
💵 $283 000 - $402 000 / an
💰 €65 000 000 Post-IPO Equity en 2012-02
⏰ Temps Plein
🟠 Senior
👨⚕️ Directeur Médical
🦅 Parrain de Visa H1B
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 5 mois
Strategic Accounts Executive driving sales growth for Medline within major healthcare accounts. Leading consultative sales and account management with a strong focus on profitability and execution.
🇺🇸 États-Unis – Télétravail
💵 $116 000 - $174 000 / an
💰 Private Equity Round en 2021-06
⏰ Temps Plein
🟠 Senior
🔴 Expert
👨⚕️ Directeur Médical
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 5 mois
Medical Director overseeing clinical trials ensuring compliance with medical guidelines. Delivering high-quality medical consultation and oversight for pharmaceutical product life-cycles at Thermo Fisher Scientific.
🗣️🇺🇸🇬🇧 Anglais requis